Substance Abuse Research Center, University of Texas Health Science Center
Houston, Texas, 77030, United States
NCT Number: NCT00000443
The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.
Looking for future studies?
Notify Me25 year–60 year
All sexes
Interventional
Phase 2
Houston, Texas, 77030, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Nih
Pharmacological Treatment for Alcoholism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03152760
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT02181569
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT03120468
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial DetailsNCT03969251
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial Details